Please ensure Javascript is enabled for purposes of website accessibility

Why Quidel Shot 4% Higher Today

By Eric Volkman - Updated Jun 30, 2021 at 1:20PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There might be a surge in demand for coronavirus testing kits in the very near future.

What happened

Quidel (QDEL) well outpaced the broader stock market on Tuesday, rising to close nearly 4% higher on a day when the S&P 500 index barely crept upwards.

The company appeared to benefit from a stark reminder from one of America's largest metropolitan areas that the coronavirus remains a serious threat.

Pregnant woman receiving a vaccine jab.

Image source: Getty Images.

So what

On Tuesday, the Los Angeles County Department of Public Health recommended that everyone wear masks indoors, whether or not they've been fully vaccinated. The new guidance comes very shortly after the state of California lifted most of its mask mandates for those who've received a full cycle of vaccine.

The big concern here is the coronavirus' rapidly spreading delta variant, which is more transmissable than the original strain that spread across the world last year.

The agency's recommendation mirrors the latest guidance from the World Health Organization. Its officials said last week that even 100% vaccinated people should continue to wear masks and engage in social distancing practices.

Now what

These recommendations illustrate the fact that we might not be close to the finish line with the coronavirus, particularly with the delta variant on the loose. This plays well into the operations of Quidel, which is a top name in healthcare diagnostics generally and COVID-19 diagnostics specifically.

Considering that almost 75% of Quidel's sales derived from COVID-19 testing kits in its most recently reported quarter, it stands to benefit significantly from a likely ramp-up in testing in the face of the frightening new variant.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Quidel. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Quidel Corporation Stock Quote
Quidel Corporation

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/15/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.